Article Information
vol. 12 no. 534
- Received for publication January 28, 2019
- Resubmitted October 14, 2019
- Accepted for publication January 28, 2020
- .
Author Information
- Johanna M. Schafer1,
- Brian D. Lehmann2,3,*,
- Paula I. Gonzalez-Ericsson3,*,
- Clayton B. Marshall1,3,*,
- J. Scott Beeler1,
- Lindsay N. Redman1,
- Hailing Jin3,
- Violeta Sanchez3,
- Matthew C. Stubbs4,
- Peggy Scherle5,
- Kimberly N. Johnson3,
- Quanhu Sheng6,
- Joseph T. Roland7,
- Joshua A. Bauer1,8,
- Yu Shyr6,
- Bapsi Chakravarthy3,9,
- Bret C. Mobley10,
- Scott W. Hiebert1,3,
- Justin M. Balko2,3,
- Melinda E. Sanders3,10,
- Phillip C. C. Liu11 and
- Jennifer A. Pietenpol1,3,†
- 1Department of Biochemistry, Vanderbilt University, Nashville, TN 37232, USA.
- 2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 3Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 4Incyte Corporation, Wilmington, DE 19803, USA.
- 5Prelude Therapeutics, Wilmington, DE 19803, USA.
- 6Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 7Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 8Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232, USA.
- 9Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 10Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- 11Kymera Therapeutics, Cambridge, MA 02139, USA.
- ↵†Corresponding author. Email: j.pietenpol{at}vumc.org